4Front Ventures

Vertically-Integrated, Multi-State Cannabis Operation

This 4Front Ventures profile is part of a paid investor education campaign.*

Overview

4Front Ventures Corp. (CSE:FFNT, OTC:FFNTF) is a cannabis company formed by the merging of 4Front and Cannex, two companies with unique, definable and complementary skillsets. The company is designed for long-term success and built upon battle-tested operating capabilities, experienced and aligned leadership, a strategic asset base and a commitment to being a magnet for talent.

4Front was founded in 2011 as a regulatory and operations consultant to dispensary operators. The company’s roots were in developing best practices for the operation of professional medical cannabis dispensaries, ensuring that retail customers and their experiences remain a focus.

Cannex’s leadership founded its Washington cultivation and production operations in 2012. The team demonstrated that the company can execute at scale in highly-competitive environments. These proven operational capabilities have helped 4Front to successfully scale production, distribution and sales in the company’s chosen markets.

The company owns and operates 11 dispensaries operating across seven states with additional dispensaries under development in five of those states.

4Front’s wellness division in California currently sells CBD products online throughout the US with a full line of CBD and THC wellness products available through retail stores. The wellness division also offers an overnight cannabis delivery service, with a network that covers approximately 93 percent of California’s operations.

From plant genetics to the cannabis retail experience, 4Front’s team applies expertise across the value chain. The company has invested heavily in assembling a comprehensive collection of management skills and hands-on operating expertise to capitalize on the unique growth opportunity being afforded by the increased legalization of cannabis.

4Front Ventures Company Highlights

  • Battle-tested operating capabilities.
  • 4Front owns or operate five cultivation facilities across three states: Illinois, Massachusetts, and Washington. Their newest cultivation facility in Elma, Wash., boasts yields of more than 400g/sq. ft.
  • 4Fronts production division Brightleaf, owns 20+ brands across more than 300 SKUs, which are distributed to over 60% of Washington’s cannabis retailers. Brightleaf’s facility in Tumwater, Wash., manufactures more than 100,000 extract cartridges, 200,000 edible packs, and 200,000 pre-rolls per month.*
  • 4Front has helped stand up, staff and operate more than 20 dispensaries in nine states since 2011.
  • 4Front’s regulatory expertise stems from its initial advisory and licensing business. The company’s regulatory team has helped their clients secure more than 60 operating licenses across 10 states.
  • 4Front’s business development team is prioritizing organic new market opportunities and potential acquisition prospects.
  • Experienced and aligned leadership – since inception, 4Front’s leadership has invested over US$8 million in the company.
  • Strategic and invested leadership with a great mix of industry veterans and emerging industry talent.
  • Commitment to being a magnet for talent – 4Front employs approximately 300 people, over 550 when including strategic partners.*

*Brightleaf’s facilities in Washington are operated by Northwest Cannabis Solutions (“NWCS”) (Tumwater facilities), and 7Point Holdings LLC (7P) (Elma facility). Brightleaf leases the facilities to NWCS and 7P, and additionally licenses its brand names and intellectual property, sells non-cannabis inputs to, and provides growing consulting services to NWCS. Washington state law currently forbids the out of state ownership of cannabis licenses. Brightleaf maintains options to purchase both NWCS and 7P if and when the law changes. Accordingly, NWCS is included in Brightleaf’s “Systemwide Pro Forma Revenue”.

4Front’s Multi-State Assets

4Front Ventures has three divisions that cover cultivation, production & manufacturing, retail and wellness. Brightleaf oversees six cultivation and manufacturing facilities in Washington, Illinois and Massachusetts. The company also has the licenses in place to develop product manufacturing facilities in Arizona and California.

Mission currently operates 11 cannabis dispensaries in seven states. The company expects to organically own, operate or manage 12 retail locations by the end of 2019. Pure Ratios sells wellness products that marry cannabinoids with traditional ingredients used in eastern medicine, as well as a line of hemp-derived CBD products sold nationwide.

Brightleaf (Production)

First Generation: Tumwater, Washington

In 2014, 4Front completed construction on a 72,000-square-foot cultivation facility. In 2018, NWCS reported yields of over 350 grams per square foot from the facility. The property also features a 56,500-square-foot processing space that manufactures more than 100,000 cartridges, 200,000 edible packs and 200,000 pre-rolls per quarter.

Second Generation: Elma, Washington

In 2016, 4Front finished construction on a 60,000-square-foot cultivation facility. The company’s operating partner reported yields of over 400 grams per square foot in 2018.

Third Generation: Massachusetts, Illinois, and California

4Front has two facilities in Massachusetts. The 67,000-square-foot Georgetown facility and the 21,700-square-foot Worchester facility each include cultivation and manufacturing space. The company also has a 94,000-square-foot cultivation and manufacturing facility in Elk Grove Village, Illinois and is currently building a 190,000-square-foot manufacturing facility in Commerce City, California.

Mission (Retail)

Through its subsidiary, 4Front has developed an extensive retail presence in several states across the US.

  • Massachusetts — Three dispensaries licensed for medical operations, with adult use expansions pending; additional Mission stores in the works through brand licensing agreements
  • Illinois — One dispensary with additional location in the queue after passage of adult-use bill
  • Pennsylvania — One dispensary operating, with two additional locations licensed and under development
  • Maryland — Three dispensaries operating under licensing agreements; one dispensary to open pending regulatory inspection
  • Arkansas – One dispensary operating, with two additional locations licensed and under development
  • Arizona — One dispensary
  • Michigan — One dispensary

Pure Ratios (Wellness)

Founded by two natural health practitioners with over 45 years of combined hands-on experience, Pure Ratios’ origins are rooted in natural medicine and science, technology and holistic medicine. The company has developed proprietary formulations that were created by long-time practitioners of eastern medicine.

Creators of the award-winning 96-hour pain relief patch, the first and only pain management product of its kind, the Pure Ratio patches utilize topical delivery of CBD and THC. Through this method, the CBD or THC bypasses the digestive process for an undiluted absorption of cannabinoids directly into the bloodstream.

4Front Ventures’ Management Team

Josh Rosen – CEO

Josh provided seed capital to Kris Krane to form 4Front Advisors in 2011 and joined as a full-time team member in 2014 when 4Front began to explore opportunities beyond consulting. Previously, he spent 13 years as an equity analyst and portfolio manager in the financial services industry, during which time he became one of the youngest vice presidents in Credit Suisse’s history. Josh moved into private equity in 2008 because he wanted to have a more meaningful impact on companies.

Kris Krane – President

Having founded 4Front Advisors in 2011, Kris now serves as president of 4Front. Prior to forming 4Front, Kris served as director of client services for CannBe, a pioneer in developing best practices within the medical cannabis industry. Kris has dedicated his career to reforming the nation’s misguided drug policies, having previously served as associate director of NORML (2000-2005) and executive director of Students for Sensible Drug Policy (2006-2009). He currently serves on the National Cannabis Industry Association board of directors and pens a column about the cannabis industry for Forbes. Kris’ pioneering roots in cannabis advocacy and policy provides a deep understanding of the evolving regulatory environment, which often provides 4Front a head-start on seeing and evaluating opportunities.

Andrew Thut – Chief Investment Officer

Andrew was an early investor in 4Front, joining the company full time in 2014. He brings to the team a wealth of financial-management experience and business acumen having previously served as managing director of the BlackRock Small Cap Growth Fund at BlackRock Advisors LLC. During his 11-year involvement, the $2 billion fund ranked in the top five percent of all domestic small cap growth funds. He also had past experiences at MFS Investment Management and BT Alex Brown. Since joining 4Front, he has immersed himself in every facet of the cannabis industry, from the relevant financial drivers of the industry to hands-on experience with dispensaries and cultivation facilities.


*Disclaimer: This profile is sponsored by 4Front Ventures (CSE:FFNT; OTCQX:CNXXF). This profile provides information which was sourced by the Investing News Network (INN) and approved by 4Front Ventures, in order to help investors learn more about the company. 4Front Ventures is a client of INN. The company’s campaign fees pay for INN to create and update this profile.

INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.

The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with 4Front Ventures and seek advice from a qualified investment advisor.